José A. Crippa

3.4k total citations
47 papers, 2.5k citations indexed

About

José A. Crippa is a scholar working on Pharmacology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, José A. Crippa has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 14 papers in Cognitive Neuroscience and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in José A. Crippa's work include Cannabis and Cannabinoid Research (25 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Schizophrenia research and treatment (6 papers). José A. Crippa is often cited by papers focused on Cannabis and Cannabinoid Research (25 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Schizophrenia research and treatment (6 papers). José A. Crippa collaborates with scholars based in Brazil, United Kingdom and Australia. José A. Crippa's co-authors include Antônio Waldo Zuardi, Jaime E. C. Hallak, Francisco Silveira Guimarães, Rocı́o Martı́n-Santos, Alline C. Campos, Philip McGuire, Sagnik Bhattacharyya, Stefan Borgwardt, Paul Allen and Paolo Fusar‐Poli and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

José A. Crippa

46 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José A. Crippa Brazil 24 1.4k 619 539 396 390 47 2.5k
Chandni Hindocha United Kingdom 28 1.9k 1.3× 644 1.0× 457 0.8× 322 0.8× 448 1.1× 52 2.4k
José Alexandre S. Crippa Brazil 22 2.1k 1.5× 859 1.4× 587 1.1× 370 0.9× 616 1.6× 45 3.0k
Rajiv Radhakrishnan United States 29 1.1k 0.8× 549 0.9× 366 0.7× 555 1.4× 495 1.3× 83 2.5k
Marcos Hortes Nisihara Chagas Brazil 29 1.5k 1.1× 594 1.0× 946 1.8× 507 1.3× 535 1.4× 113 3.4k
Philip Robson United Kingdom 22 3.1k 2.2× 1.1k 1.7× 738 1.4× 509 1.3× 571 1.5× 36 4.0k
Ziva D. Cooper United States 33 2.0k 1.4× 1.0k 1.7× 278 0.5× 249 0.6× 378 1.0× 103 2.9k
C. H. Ashton United Kingdom 21 1.2k 0.8× 422 0.7× 364 0.7× 414 1.0× 369 0.9× 44 2.5k
Richard C. Shelton United States 31 1.5k 1.1× 818 1.3× 411 0.8× 905 2.3× 549 1.4× 65 3.9k
Stefania Bonaccorso United Kingdom 25 675 0.5× 722 1.2× 502 0.9× 1.1k 2.7× 285 0.7× 35 3.2k
Wiesław Jerzy Cubała Poland 25 891 0.6× 280 0.5× 263 0.5× 680 1.7× 253 0.6× 183 2.4k

Countries citing papers authored by José A. Crippa

Since Specialization
Citations

This map shows the geographic impact of José A. Crippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Crippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Crippa more than expected).

Fields of papers citing papers by José A. Crippa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Crippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Crippa. The network helps show where José A. Crippa may publish in the future.

Co-authorship network of co-authors of José A. Crippa

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Crippa. A scholar is included among the top collaborators of José A. Crippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Crippa. José A. Crippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Issy, Ana Carolina, et al.. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior. 245. 173879–173879. 4 indexed citations
2.
Almeida, Valéria de, et al.. (2024). Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modifications. Acta Neuropsychiatrica. 36(5). 330–336. 2 indexed citations
3.
4.
Ferreira, Frederico Rogério, Jaime E. C. Hallak, Antônio Waldo Zuardi, et al.. (2022). Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology. 239(9). 2713–2734. 27 indexed citations
5.
Smith, Bradley J., Lícia C. Silva-Costa, Aline Gazzola Fragnani Valença, et al.. (2021). Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Frontiers in Molecular Neuroscience. 14. 673144–673144. 3 indexed citations
6.
Vuolo, Francieli, Soraia C. Abreu, Monique Michels, et al.. (2018). Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology. 843. 251–259. 97 indexed citations
7.
Linares, Ila Marques Porto, Francisco Silveira Guimarães, Álan Luiz Éckeli, et al.. (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Frontiers in Pharmacology. 9. 315–315. 69 indexed citations
8.
Zuardi, Antônio Waldo, et al.. (2017). Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life. Frontiers in Pharmacology. 8. 259–259. 223 indexed citations
9.
10.
Torres, Ulysses S., Fábio Duran, Maristela S. Schaufelberger, et al.. (2016). Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness. NeuroImage Clinical. 12. 1–15. 95 indexed citations
11.
Trzesniak, Clarissa, Ila Marques Porto Linares, Tonicarlo Rodrigues Velasco, et al.. (2015). Adhesio interthalamica and cavum septum pellucidum in mesial temporal lobe epilepsy. Brain Imaging and Behavior. 10(3). 849–856. 20 indexed citations
12.
Crippa, José A., et al.. (2015). Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis. CNS & Neurological Disorders - Drug Targets. 14(8). 970–978. 11 indexed citations
13.
Machado‐de‐Sousa, João Paulo, Flávia de Lima Osório, Andrea Parolin Jackowski, et al.. (2014). Increased Amygdalar and Hippocampal Volumes in Young Adults with Social Anxiety. PLoS ONE. 9(2). e88523–e88523. 64 indexed citations
14.
Crippa, José A., Jaime E. C. Hallak, & Antônio Waldo Zuardi. (2013). Marijuana, feijoada and the debate on drug legalization. Frontiers in Psychiatry. 4. 7–7. 6 indexed citations
15.
Nardi, Antônio Egídio, Sérgio Machado, Flávia Paes, et al.. (2013). Clonazepam for the Treatment of Panic Disorder. Current Drug Targets. 14(3). 353–364. 20 indexed citations
16.
Chagas, Marcos Hortes Nisihara, José A. Crippa, Sônia Regina Loureiro, et al.. (2011). Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: Two questions and one important answer. Aging & Mental Health. 15(7). 838–843. 28 indexed citations
17.
Navinés, Ricard, José A. Crippa, Ana B. Fagundo, et al.. (2010). Depersonalization and personality in panic disorder. Comprehensive Psychiatry. 52(4). 413–419. 22 indexed citations
18.
Meneses-Gaya, Carolina de, Antônio Waldo Zuardi, Sônia Regina Loureiro, et al.. (2010). Is the Full Version of the AUDIT Really Necessary? Study of the Validity and Internal Construct of Its Abbreviated Versions. Alcoholism Clinical and Experimental Research. 34(8). 1417–1424. 145 indexed citations
19.
Hallak, Jaime E. C., Serdar Dursun, João Paulo Machado-de-Sousa, et al.. (2010). The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(1). 198–202. 67 indexed citations
20.
Borgwardt, Stefan, Paul Allen, Sagnik Bhattacharyya, et al.. (2008). Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition. Biological Psychiatry. 64(11). 966–973. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandni Hindocha Breakdown of academic impact, for papers by José Alexandre S. Crippa Breakdown of academic impact, for papers by Rajiv Radhakrishnan Breakdown of academic impact, for papers by Marcos Hortes Nisihara Chagas Breakdown of academic impact, for papers by Philip Robson Breakdown of academic impact, for papers by Ziva D. Cooper Breakdown of academic impact, for papers by C. H. Ashton Breakdown of academic impact, for papers by Richard C. Shelton Breakdown of academic impact, for papers by Stefania Bonaccorso Breakdown of academic impact, for papers by Wiesław Jerzy Cubała
Rankless by CCL
2026